ncRNA basic information
ncRNA ID:
ENSG00000226856
ncRNA Database:
Ensembl
ncRNA Name:
THOR
ncRNA Type:
lncRNA
ncRNA Expression:
up-regulated
ncRNA Method:
qRT-PCR
ncRNA Target Gene:
NA
ncRNA Pathway:
Hippo signaling pathway
Evidence (ncRNA-drug):
validated
drug basic information
Drug ID:
DB00515 (APRD00359)
Drug Name:
Cisplatin
Drug Method:
The role of lncRNA THOR in nasopharyngeal carcinoma cells was detected using MTT assay, transwell migration assay, qRT-PCR, western blotting, RIP assay, luciferase reporter assay, Immunofluorescent assay, in vivo tumorigenic assay, etc.
Drug Response:
resistant
Cancer basic information
Cancer:
nasopharyngeal carcinoma
Tissue/Cell:
tissue and cell line (FaDu, SCC25, HN30, HN4, SCC4, Cal27, HN13 and HN12)
Other information
Title:
LncRNA THOR attenuates cisplatin sensitivity of nasopharyngeal carcinoma cells via enhancing cells stemness.
Journal:
Biochimie
Published:
2018
PubMed ID:
29959065